Porton provides highly secure and exclusive in/out-licensing in / out services services to help global pharmaceutical companies bring their products into China, and assist Chinese pharmaceutical companies seeking overseas partners.
Working as a reliable, knowledgeable and objective bridge between Chinese and global companies, Porton’s Licensing group can facilitiate deals across small molecules, biologics, gene and cell therapeutics in life cycle stages ranging from pre-clinical to commercialization and multiple therapeutic areas including oncology, rare diseases, autoimmune diseases, metabolic disorders, cardiovascular, CNS and other areas with high unmet needs.
Our talented and hard-working Licensing Group is comprised of professionals with extensive experience of working in international and Chinese pharmaceutical companies and markets. To assist global companies efficiently enter the Chinese market, we offer Porton’s powerfully integrated CDMO services across all development phases in small molecule API, Drug Product and/or Bioloigics / Cell & Gene therapeutics.
Get to Know Us! Please contact Grace.Zhang@portonbio.com.